Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4501)
All Articles published online
|
Apr 28, 2012 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kirikoshi H, Yoneda M, Mawatari H, Fujita K, Imajo K, Kato S, Suzuki K, Kobayashi N, Kubota K, Maeda S, Nakajima A, Saito S. Is hepatic arterial infusion chemotherapy effective treatment for advanced hepatocellular carcinoma resistant to transarterial chemoembolization? World J Gastroenterol 2012; 18(16): 1933-1939 [PMID: 22563174 DOI: 10.3748/wjg.v18.i16.1933] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i16/1933.htm |
| Number | Citing Articles |
| 1 |
JIAN HUANG, GUOZHEN YANG, YUNZHU HUANG, WEIYING KONG, SHU ZHANG. 1,25(OH)2D3 inhibits the progression of hepatocellular carcinoma via downregulating HDAC2 and upregulating P21(WAFI/CIP1). Molecular Medicine Reports 2016; 13(2): 1373 doi: 10.3892/mmr.2015.4676
|
| 2 |
Kazuto Tajiri, Kengo Kawai, Masami Minemura, Satoshi Yasumura, Ayumu Hosokawa, Hideto Kawabe, Gakuto Tomizawa, Toshiro Sugiyama. Neutrophil/lymphocyte ratio as a prognostic indicator of hepatic arterial infusion chemotherapy with arterial cisplatin plus continuous 5‐fluorouracil. Hepatology Research 2015; 45(7): 755 doi: 10.1111/hepr.12417
|
| 3 |
Chao An, Ran Wei, Wang Yao, Wenwen Han, Wang Li, Ge Shi, Peihong Wu. Association of serum AFP trajectories and hepatocellular carcinoma outcomes after hepatic arterial infusion chemotherapy: A longitudinal, multicenter study. Cancer Medicine 2024; 13(11) doi: 10.1002/cam4.7319
|
| 4 |
Bohuslav Melichar, Josef Dvorak, Alexander Ferko, Katerina Kamaradova, Antonin Krajina. Hepatic arterial infusion in hepatocellular carcinoma: a single center experience. Biomedical Papers 2015; 159(1): 139 doi: 10.5507/bp.2014.054
|
| 5 |
Hyung Joon Yim, Sang Jun Suh, Soon Ho Um. Current management of hepatocellular carcinoma: An Eastern perspective. World Journal of Gastroenterology 2015; 21(13): 3826-3842 doi: 10.3748/wjg.v21.i13.3826
|
| 6 |
Myung Jin Oh, Heon Ju Lee, Si Hyung Lee. Efficacy and safety of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma as first-line therapy. Clinical and Molecular Hepatology 2013; 19(3): 288 doi: 10.3350/cmh.2013.19.3.288
|
| 7 |
Baojiang Liu, Xu Zhu, Song Gao, Jianhai Guo, Xiaodong Wang, Guang Cao, Linzhong Zhu, Peng Liu, Haifeng Xu, Hui Chen, Xin Zhang, Shaoxing Liu, Fuxin Kou. Safety and efficacy of hepatic arterial infusion chemotherapy with raltitrexed and oxaliplatin post-transarterial chemoembolization for unresectable hepatocellular carcinoma. Journal of Interventional Medicine 2019; 2(2): 91 doi: 10.1016/j.jimed.2019.07.006
|
| 8 |
Kenichiro Kodama, Tomokazu Kawaoka, Hiroshi Aikata, Shinsuke Uchikawa, Yuki Inagaki, Masahiro Hatooka, Kei Morio, Takashi Nakahara, Eisuke Murakami, Masataka Tsuge, Akira Hiramatsu, Michio Imamura, Yoshiiku Kawakami, Keiichi Masaki, Yoji Honda, Nami Mori, Shintaro Takaki, Keiji Tsuji, Hirotaka Kohno, Hiroshi Kohno, Takashi Moriya, Michihiro Nonaka, Hideyuki Hyogo, Yasuyuki Aisaka, Kazuaki Chayama. Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status. Journal of Gastroenterology and Hepatology 2018; 33(10): 1780 doi: 10.1111/jgh.14152
|
| 9 |
Ngoc Bich Vu, Tam Thanh Nguyen, Long Cong-Duy Tran, Cong Dinh Do, Bac Hoang Nguyen, Ngoc Kim Phan, Phuc Van Pham. Doxorubicin and 5-fluorouracil resistant hepatic cancer cells demonstrate stem-like properties. Cytotechnology 2013; 65(4): 491 doi: 10.1007/s10616-012-9511-9
|
| 10 |
Masafumi Ikeda, Shuichi Mitsunaga, Satoshi Shimizu, Izumi Ohno, Hideaki Takahashi, Hiroyuki Okuyama, Akiko Kuwahara, Shunsuke Kondo, Chigusa Morizane, Hideki Ueno, Mitsuo Satake, Yasuaki Arai, Takuji Okusaka. Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization. Journal of Gastroenterology 2014; 49(5): 932 doi: 10.1007/s00535-013-0853-7
|